JAK3 and glioblastoma: The differentiation of GBM cells from highly proliferating blasts to morphologically differentiated non-proliferating neurons induced by the JAK3 inhibitors suggests that the inhibition of JAK3 activity could, in principle, be applied as a therapeutic strategy to prevent GBM.